Background
==========

Fine particulate matter, especially that composed of particles with an aerodynamic diameter of less than 2.5 μm (PM~2.5~), has been reported to pose great public health hazards. It is an environmental factor in developing diseases such as type 2 diabetes \[[@b1-medscimonit-22-3274]\], cardiovascular disease \[[@b2-medscimonit-22-3274]\], and asthma \[[@b3-medscimonit-22-3274]\]. Even a short-term increased PM~2.5~ concentration in the air results in elevated mortality and morbidity \[[@b4-medscimonit-22-3274]\]. Recently, epidemiological evidence has shown the association between PM~2.5~ exposure and adverse perinatal outcomes, such as restricted fetal growth expressed as low birth weight (\<2500 g or small for gestational age). An epidemiological study showed that PM~2.5~ exposure during the third trimester was significantly associated with a reduction of neonatal birth weight \[[@b5-medscimonit-22-3274]\]. Neonatal head circumference and triceps and subscapular skinfold thicknesses were decreased significantly with in utero exposure to PM~2.5~ \[[@b6-medscimonit-22-3274]\].

Adverse perinatal outcome is usually regarded as an indicator of placental dysfunction \[[@b7-medscimonit-22-3274]\]. Fetal growth is dependent on nutrient availability, which in turn is related to the placenta. This oval organ is where maternal and fetal blood are brought into very close contact, so that the mother can supply oxygen and nutrients to the fetus and remove waste products from the fetal blood at the same time. This transport process depends on the morphological characteristics of placenta, such as the placental size and blood flow. In clinical and experimental studies, fetal growth retardation has been commonly regarded as a consequence of placental insufficiency. Moreover, placental insufficiency results in a variety of pregnancy complications throughout the 3 trimesters, including abortion, fetal death, and preterm labor \[[@b8-medscimonit-22-3274],[@b9-medscimonit-22-3274]\].

Based on results of previous studies, we hypothesized that PM~2.5~ can hurt placental development, subsequently promoting placental morphological changes and insufficiency, finally resulting in pregnancy complications. To date, few studies have investigated the placental changes and perinatal consequences of air pollution, and even less attention has been paid to PM~2.5~.These limited papers simply focussed on reduction of placenta weight \[[@b10-medscimonit-22-3274]\] or local placental inflammation \[[@b11-medscimonit-22-3274]\] in response to air pollution.

The mechanisms by which PM~2.5~ causes illnesses are still not well understood. Inflammation, coagulation hyperfunction, and oxidative response are the most commonly proposed mechanisms. Systemic inflammation is generally believed to be the major mediator of chronic exposure to ambient PM~2.5~ \[[@b12-medscimonit-22-3274]\]. The ultrafine particles in urban air may promote inflammation of lung epithelium, which would increase the concentrations of acute cytokines \[[@b13-medscimonit-22-3274]\] like interleukin, and in turn cause systemic inflammation. Increased plasma viscosity \[[@b14-medscimonit-22-3274]\] and elevated blood platelet level \[[@b15-medscimonit-22-3274]\] are also associated with exposure to ambient particles. Enhanced thrombosis susceptibility is shown with diesel exhaust particles exposure \[[@b16-medscimonit-22-3274]\], which indicates that ambient particles may promote the process of thrombosis in capillaries and then affect function of organs. Oxidative stress is also an important etiological mechanism underlying PM~2.5~-induced injury \[[@b17-medscimonit-22-3274]\]. PM~2.5~ inhalation can exert toxic effects on blood cells and the antioxidant system, stimulating the production of free radicals or reactive oxygen. In lungs, the antioxidative enzyme activities and lipid peroxidation levels changed markedly with obvious dose-dependent PM~2.5~ exposure \[[@b18-medscimonit-22-3274]\].

Inhaled PM~2.5~ can easily be transported from lung alveoli to capillaries, after which it is dissolved and circulated into the bloodstream via the pulmonary artery. During blood circulation, components of PM~2.5~ may enter the uteroplacental vascular system, resulting in placenta pathologic changes and decreased transplacental function, with consequent pregnancy complications such as restricted fetal growth through 1 or more action mechanisms. We designed this animal experiment to assess the effect of PM~2.5~ on perinatal outcomes, especially on placenta, and to explore the possible mechanism by which PM~2.5~ affects the placenta in utero.

Material and Methods
====================

Animals
-------

Eleven-week-old female and 12-week-old male Sprague--Dawley (SD) rats were acclimatized 2 weeks in separate cages prior to mating. The animals were maintained in a climate-controlled room under a 12-h alternating light/dark cycle, 22±2°C temperature, and 50±10% relative humidity. Pregnancy was confirmed by the presence of a vaginal mucus plug, designated as Day 1 of pregnancy. Pregnant rats were placed in individual cages under the conditions similar to the acclimatization period. All animal studies were approved by the Animal Experimental Ethics Committee of the Laboratory Animal Centre, Wenzhou Medical University, China.

PM~2.5~ sampling and processing
-------------------------------

The samples of PM~2.5~ were collected by a particulate sampler (2031 Qingdao Laoying Instruments Co. Ltd., China) through a fiberglass filter between Jan and Jun 2014 in Wenzhou, China. Filters were weighed and cut into 1--2-cm^2^ squares. The filter squares were agitated in ultrapure water with an ultrasonic shaker for 30 min ×2 times. The solution was filtered through 8 layers of gauze and centrifuged at 12 000 rpm for 20 min. The sediment was collected by a vacuum freeze drier (Christ/ALPHA2-4 LD, Germany). The dry PM~2.5~ powder was diluted in sterile saline in a concentration of 30 mg/mL and kept at −20°C before experiments \[[@b19-medscimonit-22-3274]\].

Animal groups and treatment
---------------------------

Twenty pregnant rats were randomly assigned to 2 groups: 10 in the PM~2.5~ exposure group and 10 in the control group. Rats in the PM~2.5~ exposure group received a low PM~2.5~ dose (15 mg/kg) with intratracheal instillation at day 10 and day 18. The cumulative dose of PM~2.5~ for the PM~2.5~ exposure group was 30 mg/kg. Rats in the control group received an equivalent volume of normal saline with intratracheal instillation on the same days. All the pregnant rats received cesarean section at 23 h after the last intratracheal instillation and were sacrificed with anesthesia. All fetuses were weighed on an electronic balance scale (Mettler Toledo, AL204) and morphologically evaluated.

Blood biomarkers
----------------

Blood was sampled from the arteria cruralis. Tubes were centrifuged at 1500 rpm for 10 min at 4°C. Blood routine tests (BRT) were performed within 2 h after sacrifice via a hematology analyzer (SYSMEX-XS-800i). The interleukin-6 (IL-6) levels were measured by an enzyme-linked immunosorbent assay (ELISA) kit (ab100772, Abcam, UK) following the manufacturer's instructions.

Placenta biomarkers detections
------------------------------

At the endpoint of the exposure, placenta tissues were collected after cesarean section for further analysis. Placentas were cut in half longitudinally, one piece for pathologic examinations and the other for biomarker detection. The tissues for biomarker detection were homogenized and stored at −80°C. The activities of glutathione peroxidase (GSH-Px) and methane dicarboxylic aldehyde (MDA) were detected for oxidative stress estimation with a colorimetric method assay kit (Nanjing Jiancheng Bioengineering Institute, Jiangsu, China).

Placenta pathology
------------------

Placenta tissue sections were stained using hematoxylin and eosin (HE). For histological and morphometric analysis, 10--20 fields per section were observed with digital light microscopy (Qimaging, Q36955, Canada). Placenta histological findings were reported, including thrombotic vasculopathy, chorioamnionitis, and abnormal syncytiotrophoblast cells. Syncytiotrophoblastic nodules are characterized by 3 syncytiotrophoblastic cells fused in the villus or intervillous space. All of these pathologic processes have been linked with poor placental functions and adverse pregnancy outcomes \[[@b20-medscimonit-22-3274]--[@b22-medscimonit-22-3274]\]. Three independent, experienced observers performed semiquantitative evaluation of the slides.

Statistics
----------

Statistical analysis was performed using SPSS20.0 IBM statistical software to assess the differences between the PM~2.5~ exposed rats and the non-exposed rats. Chi-squared tests were used for categorical data and paired t-test (two-way ANOVA) for continuous data. A *p* value of less than 0.05 was considered statistically significant.

Results
=======

During the whole exposure process, 2 rats in the PM~2.5~ group and 1 in the control group aborted several hours after endotracheal intubation. At the end of our experiment there were 8 rats in the PM~2.5~ group and 9 in the control group.

Perinatal Outcomes
------------------

Blastocysts transferred into vacuoles in a single uterine segment are called absorbed blastocysts. As shown in [Table 1](#t1-medscimonit-22-3274){ref-type="table"}, 17% of blastocysts were absorbed with PM~2.5~ exposure, but only 5% were absorbed in the control group (*P*\<0.05). In contrast to results of previous research \[[@b10-medscimonit-22-3274]\], there was no difference in placenta weights between the 2 groups (*P*=0.78). The mean maternal weight gain and fetal weight in the PM~2.5~ group were lower than in the control group (*P*\<0.05). To determine whether any differences existed in the external morphology, all the fetuses were checked carefully, including counting forelimbs and hind legs; there were no obvious external malformations in fetuses delivered from either group.

Blood cell counting and IL-6 level
----------------------------------

The various blood biochemical parameters are presented in [Figure 1](#f1-medscimonit-22-3274){ref-type="fig"}. Peripheral blood mononuclear cells (PBMC), platelets, and IL-6 were increased in the PM~2.5~ group compared to the control group (*P*\<0.01). There was no significant difference in red blood cells (RBC) count between the 2 groups.

Placenta oxidative parameters expression
----------------------------------------

To determine if there was severe oxidative injury in placentas rats in the PM~2.5~ group, GSH-Px and MDA of placenta homogenate were detected and are illustrated in [Figure 1](#f1-medscimonit-22-3274){ref-type="fig"}. The placenta tissues with PM~2.5~ exposure tended to have a greater MDA (*p*=0.13) and a lower GSH-Px (*p*=0.11), but no significant difference was found between the 2 groups.

Placenta pathology
------------------

All the exposed placentas demonstrated at least 1 abnormal pathological finding ([Figure 2C--2H](#f2-medscimonit-22-3274){ref-type="fig"}). Extensive neutrophilic granulocyte infiltration (87.50%) was the most common microscopic finding ([Figure 2C, 2D](#f2-medscimonit-22-3274){ref-type="fig"}), followed by placental thrombus (62.50%, [Figure 2E](#f2-medscimonit-22-3274){ref-type="fig"}), fibrin deposition (37.50%, [Figure 2F](#f2-medscimonit-22-3274){ref-type="fig"}) in fetal surface, and serious amnionitis (25.00%) with papillae loss and epithelial cell necrocytosis and shedding ([Figure 2G](#f2-medscimonit-22-3274){ref-type="fig"}). Syncytiotrophoblast cells hyperplasia was common and some specimens showed syncytiotrophoblast nodules (25.00%, [Figure 2H](#f2-medscimonit-22-3274){ref-type="fig"}).

As expected, no pathological change was observed in any of the controls ([Figure 2A, 2B](#f2-medscimonit-22-3274){ref-type="fig"}). The placental villi were tortuous structures ([Figure 2B](#f2-medscimonit-22-3274){ref-type="fig"}) without neutrophilic granulocyte infiltration ([Figure 2A](#f2-medscimonit-22-3274){ref-type="fig"}).

Discussion
==========

PM~2.5~, a complex mixture of particles with an aerodynamic diameter of less than 2.5 μm, consists of smoke, haze, and gas emissions. These are the smallest particles in the air with the highest likelihood of being inhaled, but they cannot be breathed out. They subsequently enter the systemic circulation, and ultimately cause negative health effects. Exposure to PM~2.5~ is known to induce failure of several organs and cause cardiovascular \[[@b4-medscimonit-22-3274]\] and chronic pulmonary diseases \[[@b23-medscimonit-22-3274]\].

A growing body of epidemiological evidence suggests that ambient air pollution has adverse effect on maternal and fetal development. Candace et al. found that maternal exposure to traffic-related air pollution increased the risk of gestational diabetes mellitus \[[@b24-medscimonit-22-3274]\]. A population-based cohort study investigated the stillbirth rate and local PM~2.5~ concentration, and reported that exposure to high levels of PM~2.5~ in the third trimester of pregnancy was associated with 42% increased risk of stillbirth \[[@b25-medscimonit-22-3274]\]. A study with a population consisting of 48 172 full-term live births in the state of Georgia, USA, used county-level PM~2.5~ data from the U.S. Environmental Protection Agency and reported that infants with maternal exposure to PM~2.5~ were at increased risk of low birth weight \[[@b26-medscimonit-22-3274]\].

The tidal volume of rats is about 0.16 L and the respiratory rate is 70--110 breaths per minute \[[@b27-medscimonit-22-3274]\]. The average PM~2.5~ concentration in Beijing in 2014 was as high as 85.9 μg/m^3^ \[[@b28-medscimonit-22-3274]\]. Therefore, the equivalent daily PM~2.5~ exposure dose for rats would be about 1.4--2.2 mg/d, and the normal total dose in 19 pregnant days could be about 27--42 mg. In our study we used one-fifth of this normal total concentration (30 mg/kg). Under this PM~2.5~ exposure dose, the pregnant rats in our study still experienced more blastocysts lose, and retarded maternal weight gain and fetal weight compared to non-exposed rats. Our findings confirmed the effect of ambient particles on pregnant rats.

Combined with placenta pathological findings, these poor perinatal outcomes may be associated with placental abnormalities. The placenta acts as a bridge between mother and fetus. Fetal nutrient and oxygen supply, waste removal, and protection from xenobiotics rely on normal maternal-fetal circulation. The chorioamnionitis, amnionitis, and vessel thrombus observed in rats exposed to PM~2.5~ are regarded as an intrauterine inflammatory condition \[[@b29-medscimonit-22-3274]\]. They may result in failure of the placenta to nourish the fetus and can result in pregnancy complications such as preterm birth \[[@b30-medscimonit-22-3274]\], neonatal cerebral palsy \[[@b31-medscimonit-22-3274]\], fetal growth restriction \[[@b32-medscimonit-22-3274]\].

There are 3 potential mechanisms of PM~2.5~ exposure proposed by previous studies: high oxidative stress \[[@b33-medscimonit-22-3274]\], hypercoagulability \[[@b34-medscimonit-22-3274]\], and inflammation \[[@b12-medscimonit-22-3274]\]. For placenta, PM~2.5~-mediated inflammation may play a major role during the exposure. Due to its small size, PM~2.5~ can reach the alveoli. Although these small airborne particles can be eliminated by bronchial epithelial cells, there are still some that remain and subsequently pass into the blood stream. The particles are recognized as foreign matter, the local immune response is activated, and proinflammatory cytokines are released \[[@b35-medscimonit-22-3274]\]. Continued airborne particulate exposure leads to locally elevated concentrations of proinflammatory cytokines in the lung. This local immune response is thought to "spill over" into the circulation and trigger cellular inflammatory responses in various tissues. Finally, the exposure accelerates the transit of neutrophils, expands the leukocyte pool size, and increases levels of circulating cytokines such as IL-1 and IL-6, which are used to estimate the inflammatory reaction \[[@b13-medscimonit-22-3274]\]. Brook et al. found increased PBMC and tumor necrosis factor-alpha neutrophil levels at 24 h after particulate matter exposure \[[@b36-medscimonit-22-3274]\]. In a double-blind study, healthy men were exposed to diesel exhaust particulates for 1 h and the plasma IL-6 was obviously increased at 24 h after exposure \[[@b37-medscimonit-22-3274]\]. In our study, elevated IL-6 and PBMC levels were also observed after PM~2.5~ exposure, indicating a more severe systemic inflammation reaction that may affect the placenta. Placenta chorioamnionitis with extensive neutrophilic exudate confirmed this inflammatory effect from another point of view. Moreover, PM~2.5~-exposed placenta shown amnionitis with obvious loss of papillae, which decreases surface area. The placental transport capacity may influence, and, in utero, cause oxygen and nutrient supply reduction. This could explain at least in part the high loss of blastocysts and low fetal weight with PM~2.5~ exposure.

Hypercoagulability may play an important role in PM~2.5~ exposure. Numerous studies have shown the relationship between air particulate pollutants and blood clotting. A study in China recruited a group of 76 young, healthy university students, determined their levels of plasminogen activator fibrinogen inhibitor-1 and tissue-type plasminogen activator. PM~2.5~ concentration was measured at 1 particulate matter supersite monitoring station 1 km from their campus. It revealed that urban air pollution was associated with blood coagulation in healthy young humans \[[@b38-medscimonit-22-3274]\]. Rückerl found the plasma sCD40L, which reflects platelet activation, increased under ambient air pollution conditions in Germany \[[@b38-medscimonit-22-3274],[@b39-medscimonit-22-3274]\]. Recently, Kloog et al. investigated effects of daily exposure to PM~2.5~ in each ZIP code of 453 413 deep vein thrombosis (DVT) patients and 151 829 pulmonary embolism (PE) patients. They found that a 10-μg m (−3) increase in short-term PM~2.5~ exposure was associated with a 0.63% increase in DVT admissions and a 6.98% increase in long-term exposure admissions. For PE, the associated risks were 0.38% and 2.67% \[[@b40-medscimonit-22-3274]\]. Similarly, hypercoagulable state was found in our study. Thrombi were seen microscopically in most of the placentas of the PM~2.5~ exposure group and the average blood platelet count clearly increased after PM~2.5~ exposure. High platelet count may affect blood coagulation, perhaps due to direct interactions of circulating PM~2.5~ constituents with platelets, or due to an acute-phase response to the circulation inflammation, or other reasons. PM~2.5~ exposure resulted in thrombosis of placental capillaries. The vascular block reduces surface area for the transfer of substrates from mother to fetus and may contribute to placental dysfunction. Such placenta morphological and functional changes may consequently lead to decreased fetal growth.

Oxidative response may not be an important mechanism in placenta impairment. A state of high oxidative stress is a condition in which levels of free radicals or reactive oxygen are higher than normal. GSH-Px is an enzyme whose main biological role is to protect the body from oxidative damage. The biochemical function of GSH-Px is to reduce lipid hydroperoxides to their corresponding alcohols and to reduce free hydrogen peroxide to water. MDA is the ultimate degraded products of oxygen free radical peroxidation. The levels of these markers are altered in many organs after ambient particles exposure, such as lung \[[@b41-medscimonit-22-3274]\] and liver \[[@b42-medscimonit-22-3274]\]. But in our study, these 2 biomarkers had not significantly different in placenta tissues of the 2 groups. Low-dose exposure during pregnancy may be one reason, and the differential expression level of the 2 makers due to the organ difference may be another reason. However, our findings indicate that oxidative stress does not play a major role in the placenta abnormality during PM~2.5~ exposure.

Conclusions
===========

Our study provides direct evidence that PM~2.5~ exposure can cause adverse perinatal outcomes. Placenta of PM~2.5~-exposed rats revealed a number of pathologic changes in comparison to the controls. Placental inflammation and hypercoagulability with vascular thrombosis may play important roles in placental impairment, while oxidative stress may not. Pregnant women should avoid PM~2.5~ exposure.
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![Systemic inflammation, blood platelet count, and placenta oxidative stress with exposure to PM~2.5~. The peripheral blood mononuclear cells (PBMC) (**A**), platelet (**B**), and interleukin-6 (IL-6) (**C**) were higher in the test group compared to the control group (\* *p*\<0.01), but red blood cell count (**D**) was not. The glutathione peroxidase (GSH-Px) (**E**) and malondialdehyde (MDA) (**F**) of placenta homogenate were not significantly different between the 2 groups.](medscimonit-22-3274-g001){#f1-medscimonit-22-3274}

![Hematoxylin and eosin (HE) staining of placental tissue. (**A, B**) Non-exposed placental tissue did not shown abnormal pathological changes; (**C--H**) Placental tissues from PM~2.5~ exposure rats were described by: (**C, D**) placental infiltration of neutrophilic granulocytes involving amniotic membrane (**E**) thrombus (black triangle), (**F**) focal fibrinoid (black arrow), and (**G**) amnion with flat papillae and desquamated epithelial cells \[=200×\]. (**H**) Syncytiotrophoblast nodule (white arrow) observed from exposed placenta \[=400×\].](medscimonit-22-3274-g002){#f2-medscimonit-22-3274}

###### 

Maternal-fetal-placenta weight (in grams, mean ±SEM) and the number of absorbed blastocyst in test group and control.

  Group     n   Maternal weight   Fetal weight                                                       Fetus                                                           Absorbed blastocyst   Placenta weight                                          
  --------- --- ----------------- ------------------------------------------------------------------ --------------------------------------------------------------- --------------------- -------------------------------------------------------- -----------
  Control   9   288.22±20.27      368.89±34.01                                                       4.08±1.10                                                       109                   6                                                        0.66±0.10
  PM~2.5~   8   274.90±10.18      313.63±15.23[\*](#tfn1-medscimonit-22-3274){ref-type="table-fn"}   3.11±1.54[\*](#tfn1-medscimonit-22-3274){ref-type="table-fn"}   80                    17[\*](#tfn1-medscimonit-22-3274){ref-type="table-fn"}   0.65±0.08

*P*\<0.05 in PM~2.5~ exposure group compared with controls.
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